Founder And CEO
Co-Founding Partner and COO
Chief Financial Officer
Chief People Officer
Chief Growth Officer
Partner, Launch Excellence Practice Lead
Partner
Partner, Patient Services Practice Lead
Principal, Market Access
Principal, Medical Communications
Principal, Value and Access Communications
Principal, Evidence and Value
Partner
Principal, Science and Strategy
General Manager, Sr. Partner
Principal
Partner
Principal, Market Access
Principal, Market Access
Principal
Principal, Science and Strategy
Chief Growth Officer
Vice President, Commercialization
Senior Vice President, Commercialization
Vice President, Business Development
Executive Vice President, Business Development
Senior Vice President, Commercialization
Ryan is an accomplished executive with more than 20 years of progressive experience in market research and strategy consulting. He has served in nearly every level of the consulting spectrum, beginning as an entry-level survey associate and rising to VP of Consulting for a large, multinational research firm, before turning to his current position as co-founder and MD with Adivo Associates.
He is known most for his commitment to excellence, a work ethic that fueled his bottom-up career progress and is currently instantiated in Adivo’s consulting ethos. We will never have a dissatisfied client; we pride ourselves, from top-to-bottom, on our track record of excellence and repeat business that is a testament to this ideal.
Throughout his career Ryan has led more than 300 client engagements, ranging from market landscape and SWOT studies to M&A due diligence and growth consulting. Ryan is a recognized industry expert in several rare-disease areas. Here, he has focused on innovative approaches to sourcing the most accurate, and most detailed, data in what are otherwise challenging, underserved, markets. He helped originate and expand Adivo’s proprietary collection platform -a distinguishing asset currently in service across dozens of specialty markets and countries globally.
Ryan studied statistics and social sciences at the University of California, Santa Barbara and San Jose State University and graduated magna cum laude in 1995.
A prominent pharmaceutical company launching its first to market gene therapy in a rare disease was seeking to enhance its market position and reimbursement approach.
Careers page, Principal profile
"*" indicates required fields
Careers page Analyst profile
Careers page Manager profile